A Study of AK104( an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer
Akeso
Akeso
BeiGene
pharmaand GmbH
Ruhr University of Bochum
Ruhr University of Bochum
China Medical University Hospital
Daiichi Sankyo
Yonsei University
Amgen
Daiichi Sankyo
Japan Clinical Oncology Group
Stanford University
Merck KGaA, Darmstadt, Germany
Sun Yat-sen University
University of Arkansas